This two day networking event will review recent developments in the orphan drug and rare diseases industry and provide attendees with the opportunity to gain in-depth knowledge by; learning about key strategies and collaborations to accelerate rare disease clinical drug development; enhancing knowledge on the role of patient organisations in promoting drug development for their disease and discover how gene therapy is a very real factor in clinical trials.
Key topics include:
- The development of ultra-orphan drugs to prevent, diagnose and treat rare diseases
- Strategies for overcoming the challenges for reimbursement of orphan and ultra-orphan drugs
- How to create workable partnerships for future development of drugs
Find more information on the website of the conference: www.orphandrugs-event.com/antibodies